Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the...

Area of Science:

• Oncology and Pharmacology
• Computational Chemistry and Drug Design

Background:

• Cancer management is a major global health concern, driving innovation in drug discovery.
• Drug repurposing and computational methods are key strategies to accelerate the development of new cancer therapies.
• In silico approaches significantly reduce the time, cost, and effort associated with drug development.

Purpose of the Study:

• To review the integration of computational methods, particularly unbiased molecular dynamics (UMD) simulations, into drug repurposing pipelines for cancer treatment.
• To introduce and discuss a pipeline for utilizing UMD simulations in rational drug discovery.
• To demonstrate the efficacy of UMD simulations through a case study.

Main Methods:

• Utilizing computational methods like structure-based drug design (SBDD) and virtual screening to predict small molecule-target interactions.
• Employing advanced techniques such as unbiased molecular dynamics (UMD) simulations for enhanced accuracy and efficiency in drug design.
• Analyzing binding and unbinding pathways of drug-target complexes.

Main Results:

• UMD simulations offer a more sophisticated and accurate approach compared to traditional SBDD.
• The proposed pipeline effectively integrates UMD simulations to identify potential drug candidates.
• The dasatinib-c-Src kinase complex example illustrates the method's influence on understanding drug-target interactions.

Conclusions:

• UMD simulations are a powerful complementary strategy to traditional computational methods in drug repurposing.
• This approach significantly increases the likelihood of identifying effective drug candidates for cancer treatment.
• The presented pipeline and case study highlight the potential of UMD simulations in advancing rational cancer drug discovery.